RxDoctor Payments Data

Samy Badawy

Wyndmoor, PANPI 1578625497

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 137 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by AbbVie at 30.6% of the total. Reporting peaked in 2022 at $872 and has fallen 96.2% since, to $33 in 2025.

$2,503in general payments, 2019–2025

Across 137 payments — averaging $18.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$767
  • Johnson & Johnson$630
  • Sun Pharmaceutical Industries Inc.$212
  • Regeneron Healthcare Solutions, Inc.$205
  • Genentech USA, Inc.$121
  • Incyte Corporation$90
  • plus $477 from 14 others

What the payments were for

  • Food & beverage$2,503100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Where these figures come from

Is this you, or does something look wrong? →